ARTICLE | Company News
Annapurna Therapeutics, Avalanche Biotechnologies deal
May 23, 2016 7:00 AM UTC
Avalanche completed its acquisition of Annapurna for about $105.6 million in a stock deal and renamed the combined company as Adverum Biotechnologies Inc. (see BioCentury, Feb. 8). ...